Annual report pursuant to Section 13 and 15(d)

Income Taxes - Paragraphs (Details)

v3.22.2.2
Income Taxes - Paragraphs (Details) - USD ($)
 1 Months Ended 11 Months Ended 12 Months Ended
Dec. 03, 2021
Dec. 31, 2021
Dec. 02, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Tax [Line Items]            
Valuation allowance recorded       $ 9,600,000    
Deferred tax   $ 0   0 $ 0  
Net operating loss carryforwards   31,400,000   $ 31,400,000    
Maximum percentage of utilization of net operating loss carryforwards of taxable income       80.00%    
Tax benefit   0 $ 0   $ 0 $ 0
Tax Receivable Agreement with Selling Equity Holders of P3 LLC            
Income Tax [Line Items]            
Percentage of payment of tax savings realized       85.00%    
Retained percentage of cash savings       15.00%    
Network            
Income Tax [Line Items]            
Deferred tax   0   $ 0    
P3            
Income Tax [Line Items]            
TRA liability   0   0    
Tax benefit       0    
P3 | Tax Receivable Agreement with Selling Equity Holders of P3 LLC            
Income Tax [Line Items]            
Estimated potential future tax benefits $ 5,400,000          
TRA liability $ 4,600,000 0   0    
Tax benefit       0    
Medcore HP            
Income Tax [Line Items]            
Deferred tax   $ 0   $ 0